Objectives: To identify and characterize a novel MBL gene conferring carbapenem resistance to an isolate of Enterobacter cloacae from Austria.
Introduction
MBLs hydrolyse all b-lactams except monobactams, thereby frequently rendering Gram-negative bacteria resistant to penicillins, cephalosporins and carbapenems. 1 While some species such as Stenotrophomonas maltophilia possess a chromosomally encoded MBL, the increasing occurrence of MBL-mediated b-lactam resistance in clinically relevant species is usually caused by acquired MBLs. 1, 2 MBLs belong to Ambler class B and are subdivided into groups B1, B2 and B3. 1 The most prevalent acquired MBLs among Enterobacterales in Germany are the subgroup B1 MBLs, VIM-1 and NDM-1. Sporadically, other variants of the VIM and NDM family have been reported, as well as other MBL families such as GIM and IMP. 3 In Austria, VIM also is the most prevalent MBL. While the increasing availability of commercial qPCR systems allows for the detection of the most prevalent MBL families, molecular diagnostics alone are bound to overlook MBLs that belong to less prevalent MBL families. Furthermore, novel resistance genes are present in environmental reservoirs and could be introduced into clinically relevant bacterial species. 4 Here, we describe a novel subgroup B3 MBL family, named Linz MBL (LMB-1), detected in an isolate of Enterobacter cloacae belonging to ST742.
Materials and methods
The study was performed at Ruhr University Bochum.
Bacterial strains and phenotypic testing
The strain E. cloacae NRZ-10170 was isolated from a rectal swab of a patient hospitalized in 2013 in Salzburg, Austria and was first referred to the Austrian National Reference Center for Nosocomial Infections and Antimicrobial Resistance in Linz. The isolate was sent for further evaluation to Ruhr University Bochum.
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For carbapenemase detection, a modified Hodge test and a cell-free extracts-based b-lactamase microbiological assay (BMA) were performed for imipenem, meropenem and ertapenem on Mueller-Hinton agar. 5, 6 A combined disc test (CDT) with EDTA was performed for MBL detection. The Carba-NP test was performed as previously described. 7 PCR and subsequent sequencing were conducted for bla VIM , bla IMP , bla NDM , bla GIM , bla SPM , bla SIM , bla DIM , bla AIM , bla KHM and bla SMB as previously described.
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Susceptibility testing
Susceptibility testing was performed and interpreted according to EUCAST (http://www.eucast.org/clinical_breakpoints/) by microdilution using preconfigured microtitre plates (MERLIN Diagnostika GmbH, Bornheim-Hersel, Germany).
Conjugation experiments
Conjugation experiments were performed as previously described. 12 Briefly, E. cloacae NRZ-10170 and a rifampicin-resistant Escherichia coli C600 derivative were cultivated in LB broth containing 100 mg/L rifampicin or 100 mg/L ampicillin for 5 h. The cultures were mixed and cultivated overnight on Columbia blood agar at 30 C or 37 C. On the next day, cell material was resuspended in sterile 0.9% NaCl and cultivated on LB agar containing 100 mg/L rifampicin and 100 mg/L ampicillin. Transconjugants were verified by PCR and MALDI-TOF MS for species identification.
Isolation of DNA, sequencing and sequence analysis
The strain was cultivated in LB broth at 37 C until an OD 600 of 0.7 was reached. High-molecular-weight genomic DNA was isolated using the Genomic Tip 100/G kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. A Qubit 2.0 Fluorometer was used to determine the DNA concentration and confirm the absence of protein and RNA contaminations. The integrity of high-molecular-weight DNA was assessed by agarose gel electrophoresis. WGS was performed on an Illumina MiSeq platform by GATC Biotech (Konstanz, Germany) with 2%300 bp paired-end reads using libraries with an average insert size of 600 bp. Furthermore, the plasmid DNA was subjected to sequencing by Oxford Nanopore technology using the MinION device. Genome hybrid assembly from MiSeq and MinION reads was performed using the SPAdes assembler. 13 Circularization of plasmid sequences was verified by PCR. The resulting draft genome was screened for sequences homologous to known MBLs and other resistance genes using BLASTN (https://blast.ncbi.nlm.nih.gov/) and ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/). Plasmid replicon types were identified using PlasmidFinder (https://cge.cbs.dtu.dk/serv ices/PlasmidFinder/). A phylogenetic tree was deduced from the protein sequences of LMB-1 and other subclass B3 MBLs using a web-based tool (http://www.phylogeny.fr/). 14 
Cloning and heterologous expression
For comparative MIC studies, bla LMB-1 was amplified by PCR using the primers LMB-1_fwd (AAAAGAATTCCCAAACCGTAAGGCGCAGG) and LMB-1_rev (AAAAAAGCTTTTACCCGCTGGCCAAGTTGC), cloned in the vector pBK-CMV using EcoRI and HindIII and transformed into E. coli TOP10.
Isoelectric focusing
Cell-free extracts of the bla LMB-1 clone were prepared after overnight culture of test strains in 50 mL of tryptic soy broth and subsequent washing steps by sonication. For isoelectric focusing, 1.2 lL of cell-free extract, together with reference standards, was applied onto a CleanGel isoelectric focusing gel (GE Healthcare, Uppsala, Sweden). The gel was cooled during the procedure at 7 C and was run for 30 min at 500 V, 20 mA and 5 W, for 90 min at 1700 V, 20 mA and 25 W and for 30 min at 2000 V, 20 mA and 30 W.
Subsequently it was developed by spreading 2 mL of 1 mM nitrocefin evenly over the gel.
Detection of specific activity against b-lactams in crude lysates
For lysate preparation, E. coli TOP10 cells transformed with bla LMB-1 cloned in pBK-CMV were grown in LB medium containing 50 mg/L kanamycin, harvested by centrifugation and lysed using glass beads after resuspension in 50 mM HEPES containing 150 mM NaCl and 50 lM ZnSO 4 . The specific activities of the crude lysates against carbapenems, cephalosporins and penicillins were determined spectrophotometrically at 300, 260 and 235 nm, respectively. Measurements were performed in reaction volumes of 100 lL at room temperature at a final concentration of 100 lM imipenem, meropenem, ertapenem, cefotaxime, ceftazidime, cefepime, benzylpenicillin, ampicillin or piperacillin for 10 min. The total protein content of the lysates was determined using a Qubit Fluorometer. All measurements were conducted thrice.
Results and discussion
Properties of the clinical isolate E. cloacae NRZ-10170
The isolate E. cloacae NRZ-10170 belonged to MLST ST742. There is little epidemiological information on ST742, which does not belong to any clonal complex. The isolate was found to be resistant, according to EUCAST, to aminopenicillins, ureidopenicillins, oxyimino cephalosporins, meropenem, ertapenem and aztreonam by broth microdilution. Furthermore, the isolate showed intermediate or resistant MICs of tetracyclines, tigecycline, trimethoprim/sulfamethoxazole, chloramphenicol, aminoglycosides, fosfomycin and quinolones. The isolate was susceptible to colistin ( Table 1) . The modified Hodge test was positive for imipenem, meropenem and ertapenem. The EDTA-CDT was negative. The BMA showed carbapenemase activity that could be abolished by EDTA. The Carba-NP test was clearly positive after 1 h.
Sequence analysis
WGS revealed four b-lactamase genes: bla OXA-9 , bla TEM-1 , the chromosomally encoded bla AmpC gene intrinsic to E. cloacae and a gene that coded for a peptide sequence showing 99% homology with a predicted MBL (SEI10464) from the marine bacterium Rheinheimera pacifica. Furthermore, the sequence showed 42% homology to AIM-1, 38% homology to SMB-1 and FEZ-1 and 29% homology to the S. maltophilia L1 MBL. The phylogenetic tree showing the position of LMB-1 in the subclass is depicted in Figure 1 . As E. cloacae NRZ-10170 was first detected as MBL-producing in Linz, Austria, the novel b-lactamase was named Linz MBL (LMB-1). The sequence was deposited at NCBI (KU646836). The gene encoding the novel MBL LMB-1 was found to be located on a 108 kb contig that could be circularized in silico, which was confirmed by PCR. The plasmid was named pNRZ-10170-LMB-1 and was submitted to the NCBI sequence database (MH056209). While pNRZ-10170-LMB-1 comprised two different plasmid replication protein genes (repB), one of which belonged to an IncFIB(K)-type replicon, the other repB-like gene could not be typed by PlasmidFinder, but was identical to previously found repB sequences in plasmids isolated from Klebsiella pneumoniae (CP023488), Pseudomonas aeruginosa (KY883660) and Acinetobacter baumannii (MF399199). The latter repB gene was Lange et al.
directly followed by a truncated glycerophosphoryl diester phosphodiesterase gene from R. pacifica (WP_092796445) and after that by bla LMB-1 . Interestingly, this glycerophosphoryl diester phosphodiesterase gene was located upstream of the predicted MBL in R. pacifica as well (Figure 2 ). It is, therefore, tempting to speculate about a potential marine origin of the bla LMB-1 gene. Furthermore, it is likely that R. pacifica is indeed the reservoir of this type of MBL as the bla LMB-1 -like gene in R. pacifica was located on a contig (FNXF01000019) together with housekeeping genes such as a tRNA nucleotidyltransferase gene, a PBP gene, a ribosomal protein gene and an RNA polymerase sigma factor gene. It can hence be assumed that this contig is a part of the bacterial chromosome of R. pacifica and it can by hypothesized that it has been somehow mobilized into pNRZ-10170-LMB-1. The marine microflora has been identified as a possible reservoir of novel carbapenemase genes before. 4 The occurrence of bla LMB-1 in E. cloacae may constitute an example of transfer of a novel carbapenemase gene from a marine reservoir to a clinically relevant bacterial species.
Furthermore, two transposase genes (IS6 family and IS91 family, respectively) were detected upstream of the untypeable repB gene and downstream of bla LMB-1 (Figure 2 ). Possibly, one or both of them played a role in the transfer of bla LMB-1 and the glycerophosphoryl diester phosphodiesterase gene from R. pacifica or a related species into the plasmid characterized in this study. No known tra or mob genes were detected that could enable conjugal transfer of the plasmid. Consequently, pNRZ-10170-LMB-1 could not be transferred into E. coli C600 by conjugation in our experiments.
While bla TEM-1 was located 15 kb upstream on pNRZ-10170-LMB-1 and bla AmpC was found on the bacterial chromosome as expected, bla OXA-9 was located on a 138 kb contig putatively constituting a second plasmid.
Apart from genes conferring b-lactam resistance, pNRZ-10170-LMB-1 carried further resistance genes comprising dfrA1, aph(3 00 )Ib, aph(6 0 )Id, ant(3 0 )Ia, sul1 and sul2. Furthermore, the remainder of the genome contained ant(2 00 )-Ia, aadA7, aph(3 0 )-Ic, aph(6 0 )-Id, aadA1, catA1 and tet(B) according to ResFinder. The finding of these genes corresponds well with the fact that E. cloacae NRZ-10170 was resistant to aminoglycosides, chloramphenicol, sulfamethoxazole, tetracycline and trimethoprim. Furthermore, mutations previously associated with quinolone resistance were found in the genes coding for the topoisomerase subunits gyrA (D87N) and parC (S80I). 15 These mutations likely account for the detected resistance of the isolate to quinolones.
Cloning and comparative MIC studies
For phenotypic analysis of the resistance-mediating capabilities, the bla LMB-1 gene was cloned into the vector pBK-CMV and was expressed in E. coli TOP10. The expression of LMB-1 resulted in increased MICs of penicillins, cephalosporins and carbapenems, but not of aztreonam (Table 1) . No influence of b-lactamase inhibitors on the MICs could be detected. Of note, the MIC increase of imipenem and ertapenem was lower than that of meropenem and that of cefepime was lower than that of ceftazidime.
Biochemical properties of LMB-1
Isoelectric focusing revealed the LMB-1 protein's pI to be at 6.4. Crude lysates of E. coli TOP10 expressing LMB-1 revealed strong specific activity against carbapenems, oxyimino cephalosporins and aminopenicillins (Table 2) . No specific activity against aztreonam could be detected. Interestingly, no specific activity against cefepime could be detected either. LMB-1
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Most of these results correlate well with the results of the comparative MIC studies confirming activity of LMB-1 against aminopenicillins, ceftazidime, cefotaxime and carbapenems. However, in the comparative MIC studies, expression of LMB-1 accounted for an 8-fold increase in the MIC of cefepime, which indicates that LMB-1 does indeed hydrolyse cefepime. The fact that no specific activity could be detected against cefepime within 10 min indicates that the hydrolysis rates of LMB-1 for this substrate must be very low yet the hydrolysis rate appears to have been sufficiently high to account for a substantial increase in the MIC of cefepime in the comparative MIC studies.
Conclusions
In conclusion, we describe a novel MBL yielding hydrolytic activity against carbapenems and cephalosporins, thereby conferring resistance to these important antimicrobial agents for treatment of nosocomial infections caused by Enterobacterales. Sequence homology suggests that this MBL may have emerged from a marine reservoir, which underlines the ongoing transfer of resistance genes from natural reservoirs to clinically relevant species. Therefore, further surveillance of the molecular causes of carbapenem resistance is required. Lange et al.
